|
|
|
Insider
Information: |
Baird William D Iii |
Relationship: |
|
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
449,004 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,268,601 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
449,004 |
|
|
Total
Value |
$1,268,601 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
Percentage
Gain/Loss : |
0.0%
|
-153.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2018-10-15 |
117,622 |
2014-04-10 |
0 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
Chief Financial Officer |
2021-11-11 |
22,797 |
2019-03-01 |
0 |
Premium* |
|
2seventy Bio, Inc. |
TSVT |
|
2024-04-01 |
308,585 |
2022-01-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2014-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,950 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
60,975 |
96,925 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
29,803 |
124,924 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
|
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,746 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
|
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
14,641 |
36,222 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
|
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
67,169 |
102,698 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
|
2021-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,768 |
22,797 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
91,328 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
132,143 |
210,940 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
Chief Operating Officer |
|
2024-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
91,000 |
252,335 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
President and CEO |
|
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
56,250 |
308,585 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
Chief Operating Officer |
|
2024-01-05 |
4 |
S |
$3.75 |
$5,180 |
D/D |
(1,380) |
161,335 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
|
2022-02-17 |
4 |
S |
$14.78 |
$6,311 |
D/D |
(427) |
57,578 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
|
2023-02-13 |
4 |
S |
$12.86 |
$8,192 |
D/D |
(637) |
210,303 |
0 |
- |
|
TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
|
2023-01-11 |
4 |
S |
$10.63 |
$11,446 |
D/D |
(1,077) |
78,797 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2017-06-15 |
4 |
D |
$8.79 |
$13,660 |
D/D |
(1,554) |
95,371 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
|
2021-02-17 |
4 |
S |
$28.16 |
$19,516 |
D/D |
(693) |
35,529 |
0 |
% |
|
TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
|
2022-01-07 |
4 |
S |
$23.91 |
$21,421 |
D/D |
(896) |
58,005 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2018-04-02 |
4 |
OE |
$2.45 |
$24,500 |
D/D |
10,000 |
127,662 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2018-07-02 |
4/A |
OE |
$2.45 |
$24,500 |
D/D |
10,000 |
127,622 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2018-07-02 |
4 |
OE |
$2.45 |
$24,500 |
D/D |
10,000 |
117,622 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2018-10-15 |
4 |
OE |
$2.45 |
$24,500 |
D/D |
10,000 |
127,622 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|